Works matching IS 00070920 AND DT 1999 AND VI 79 AND IP 11/12


Results: 52
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Cytochrome P450 CYP3A in human renal cell cancer.

    Published in:
    British Journal of Cancer, 1999, v. 79, n. 11/12, p. 1836, doi. 10.1038/sj.bjc.6690292
    By:
    • Murray, G I;
    • McFadyen, M C E;
    • Mitchell, R T;
    • Cheung, Y-L;
    • Kerr, A C;
    • Melvin, W T
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil.

    Published in:
    British Journal of Cancer, 1999, v. 79, n. 11/12, p. 1864, doi. 10.1038/sj.bjc.6690297
    By:
    • Etienne, M C;
    • Pivot, X;
    • Formento, J L;
    • Bensadoun, R J;
    • Formento, P;
    • Dassonville, O;
    • Francoual, M;
    • Poissonnet, G;
    • Fontana, X;
    • Schneider, M;
    • Demard, F;
    • Milano, G
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Risk factors for breast cancer in nulliparous women.

    Published in:
    British Journal of Cancer, 1999, v. 79, n. 11/12, p. 1923, doi. 10.1038/sj.bjc.6690306
    By:
    • Fioretti, F;
    • Tavani, A;
    • Bosetti, C;
    • Vecchia, C La;
    • Negri, E;
    • Barbone, F;
    • Talamini, R;
    • Franceschi, S
    Publication type:
    Article
    47
    48
    49
    50

    Anthracycline dose and liver dysfunction.

    Published in:
    British Journal of Cancer, 1999, v. 79, n. 11/12, p. 1943, doi. 10.1038/sj.bjc.6690310
    By:
    • Cannizzaro, R;
    • Crivellari, D;
    • Robieux, I;
    • Sorio, R
    Publication type:
    Article